A comparison of immediate release and delayed release cysteamine in 17 patients with nephropathic cystinosis

BACKGROUND: Nephropathic cystinosis is a rare and severe metabolic disease leading to an accumulation of cystine in lysosomes which especially harms kidney function. A lifelong therapy with the aminothiol cysteamine can delay the development of end-stage renal disease and the necessity of kidney tra...

Descripción completa

Detalles Bibliográficos
Autores principales: van Stein, Christina, Klank, Sabrina, Grüneberg, Marianne, Ottolenghi, Chris, Grebe, Jürgen, Reunert, Janine, Harms, Erik, Marquardt, Thorsten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8438894/
https://www.ncbi.nlm.nih.gov/pubmed/34521447
http://dx.doi.org/10.1186/s13023-021-01991-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8438894/
https://www.ncbi.nlm.nih.gov/pubmed/34521447
http://dx.doi.org/10.1186/s13023-021-01991-2

Ejemplares similares